📢 Fully funded PhD opportunity in my group! Project title: Unravelling the origins, mechanisms and implications of species differences in cellular stress response pathway capacities. Application deadline: 7 December 2025. Details/apply: tinyurl.com/2jcp9jfz Questions: Get in touch!

(BBSRC NWD CASE) Unravelling the origins, mechanisms and implications of species differences in cellular stress response pathway capacities at University of Liverpool on FindAPhD.com

PhD Project - (BBSRC NWD CASE) Unravelling the origins, mechanisms and implications of species differences in cellular stress response pathway capacities at University of Liverpool, listed on FindAPhD...

tinyurl.com

Earlier this month I had a fantastic time in Galway, Ireland attending the SFRRI biennial meeting and the @benbedphar.bsky.social satellite meeting. Nice to catch up with friends and colleagues, including the 'Godfather' of the NRF2 field Masi Yamamoto!

Outstanding talk by @parikki.bsky.social , recipient of the CATHERINE PASQUIER AWARD LECTURE at SFFR-I Biennial Meeting in Galway @uniofgalway.bsky.social. Are ROS generated in nanodomains / condensates in cells? Want to know more, please read her paper lnkd.in/dq_6Rnaw @sfrre-ecr.bsky.social

Liverpool's @parikki.bsky.social giving the Catherine Pasquier Award lecture at the SFRRI Biennial Meeting in Galway. Fantastic talk 👏🏻 @liverpooluni.bsky.social @livuni-ismib.bsky.social @livunihls.bsky.social

A huge well done to group member Hannah Coghlan for passing her PhD viva today. It's been a pleasure to work with Hannah over the past 4 years, she deserves all of her success. Congratulations Dr Coghlan 🍾🎉👏🏻

Big congratulations to group member Hannah Coghlan for winning a poster prize at the British Toxicology Society annual meeting. Very well done 👏🏻

Fantastic presentation from group member Olivia Harris as part of the selected oral communications session at the British Toxicology Society annual congress.

After months of preparation, we're finally ready to kick off the British Toxicology Society annual congress in Liverpool. Thanks to the rest of the organising committee for making this possible. Looking forward to a great meeting!

Coming to the end of a fantastic few days in Rome participating in the @benbedphar.bsky.social meeting at Sapienza University. Great discussions about progress and next steps for NRF2 pharmacology. Managed to squeeze in a Parkrun too! 🏃🏻‍♂️

New Centre for Excellence in Regulatory Science and Innovation in #Pharmacogenomics to help UK move towards personalised prescribing: news.liverpool.ac.uk/2025/01/28/n... @livunihls.bsky.social @livuni-ismib.bsky.social @innovateuk.bsky.social @ukri.org

Nice to catch up as a group over lunch. Some great restaurant deals in January 😄

Are you a parent? Or caring for another adult, relative, friend? And are you a UK-based #academic? 🧪 We recently ran a survey (www.qualtrics.manchester.ac.uk/jfe/form/SV_...) to capture lived experiences - if you didn't complete the survey at the time, please do now. Please share w/ colleagues

✨ Happy New Year! ✨ We hope your 2025 has got off to a fantastic start! To help you plan for the year ahead, we've compiled some key dates for your diary: www.bps.ac.uk/news/article... 🧪💊🗓 #Pharmacology #ClinicalPharmacology #Pharmacogenomics #STEM #STEMEvents

Delighted to finally share our latest preprint on the role of NF-kappaB in hypoxia. Quite a few surprises!! www.biorxiv.org/content/10.1... Have a look!

NF-κB is a Central Regulator of Hypoxia-Induced Gene Expression

Hypoxia is both a physiological and pathological signal in cells. Changes in gene expression play a critical role in the cellular response to hypoxia, enabling cells to adapt to reduced oxygen availab...

biorxiv.org

As a recent recipient of this funding, I can highly recommend it as a means of broadening experiences and networks to support current and future research.

Academy of Medical Sciences@acmedsci.bsky.social · 2y ago

We’ve launched the Cross-Sector Experience Awards, a six-figure fund designed to break down barriers between sectors & accelerate health innovation. With grants of up to £100k, we’re helping talented individuals gain transformative experiences. Read more: ow.ly/VsEc50Upk0m #Grants #LifeSciences

Have you heard about TherEx, #LivUni's Centre for Experimental Therapeutics? The TherEx mission is to improve health and wellbeing by optimising the use of existing drugs and accelerating the development of new treatments. Making medicines better. ➡️ www.liverpool.ac.uk/centre-for-e...

Nice Christmas lunch combining with several @livunihls.bsky.social groups. And yes, I know it's not even December yet!

Fully funded MRC DiMeN PhD studentship available in my group starting October 2025. Come work with us in Liverpool! Identification of accessible biomarkers reflecting drug stimulation of the NRF2 antioxidant pathway in humans Deadline 13 December 2024 Informal enquiries welcome Details here...

MRC DiMeN Doctoral Training Partnership: Identification of accessible biomarkers reflecting drug stimulation of the NRF2 antioxidant pathway in humans at University of Liverpool on FindAPhD.com

PhD Project - MRC DiMeN Doctoral Training Partnership: Identification of accessible biomarkers reflecting drug stimulation of the NRF2 antioxidant pathway in humans at University of Liverpool, listed ...

findaphd.com

Registration and abstract submission now open for the 2025 British Toxicology Society annual congress. Student and carer bursaries also available. Join us in May for a great meeting in Liverpool! www.thebts.org/events/bts-a...

I'm looking forward to hosting this online meeting in January. Some great speakers lined up. Still a few days to submit abstracts and plenty of time to register. my.bps.ac.uk/events/detai...

Are you developing in vitro human liver models? Great! But be careful using paracetamol (acetaminophen) as a reference hepatotoxin - see our new article in Tox Sci for the details. Led by former PhD student Lucia Livoti. #LiverSky academic.oup.com/toxsci/advan...

Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models

Abstract. Acetaminophen is commonly used as a reference hepatotoxin to demonstrate that in vitro human liver platforms can emulate features of clinical dru

academic.oup.com

The Human Liver Research Facility here in Liverpool offers fresh & cryopreserved primary liver cells in 2D & 3D, precision cut liver slices, tissue (including perfusion soon) to academic, industry and commercial partners. Plus donor matched blood. More details: www.liverpool.ac.uk/hlrf #LiverSky

Here's a starter pack to make it easy to follow life science researchers based at the University of Liverpool. A great way to expand our networks. Get in touch if you want to be added! go.bsky.app/Fk7bp3g

Hello! We're an academic research group based at the University of Liverpool, UK. We're interested in the pharmacology and toxicology of stress response pathways. Particularly the NRF2 oxidative stress response. See here for more details www.liverpool.ac.uk/people/ian-c...